Results 21 to 30 of about 1,458 (206)

Treatment of allergic conjunctivitis with olopatadine [PDF]

Acta clinica Croatica. Supplement, 2008
Allergy symptoms that affect the eyes are common in adults and children worldwide. Ocular allergies cause itching, chemosis, tearing, redness, and swelling of the eyelids in sensitized individuals. This is a preliminary report on a study aimed at assessing the olopatadine therapy efficacy in resolving the signs and symptoms of allergic conjunctivitis ...
Cvitanović, Slavica, Miljak, Snježana, Karaman, Ksenija, Marković, Irena, Siničić, Alen, Znaor, Ljubo   +5 more
core   +3 more sources

Comparison of Allergic Rhinitis Treatments on Utilities and Quality of Life: A MASK-air Study. [PDF]

Clin Exp Allergy
This mHealth study has shown that fixed combinations of intranasal antihistamines and corticosteroids were associated with higher quality of life than oral antihistamines and intranasal antihistamines. Both intranasal corticosteroids and oral antihistamines were associated with higher quality of life than intranasal antihistamines.
Lourenço-Silva N, Sousa-Pinto B, Bognanni A, Pereira AM, Coutinho-Almeida J, Amaral R, Brussino L, Giovannini M, Gemicioglu B, Kvedariene V, Larenas-Linnemann DE, Marques-Cruz M, Papadopoulos NG, Pham-Thi N, Regateiro FS, Toppila-Salmi SK, Samolinski B, Sastre J, Taborda-Barata L, Valiulis A, Vecillas LL, Ventura MT, Pfaar O, Fonseca JA, Zuberbier T, Klimek L, Bousquet J, Vieira RJ.   +27 more
europepmc   +2 more sources

Reproxalap - A Novel Treatment Option for Allergic Conjunctivitis - A Comprehensive Narrative Review. [PDF]

Health Sci Rep
ABSTRACT Background and Aims Allergic conjunctivitis is a prevalent, immune‐mediated hypersensitivity disorder of the ocular surface affecting 10%–20% of the global population. Current therapeutic options, while effective to some extent, are often limited by side effects and inconsistent efficacy.
Mughal S, Awan RE, Abbas H, Sania Z, Habib A, Sakina SK, Mahmud A, Eljack MMF.   +7 more
europepmc   +2 more sources

Use of Artificial Intelligence-Based Platforms to Support Searches in Evidence Synthesis Studies: A Study of the EAACI Methodology Committee. [PDF]

Clin Transl Allergy
ABSTRACT Objective To demonstrate an evaluation of the use of artificial intelligence (AI) in supporting tasks in evidence synthesis (particularly search for primary studies) in the allergy or respirology fields. Methods We queried three AI‐based platforms specialised on identifying scientific publications using several strategies (i.e., prompting ...
Sousa-Pinto B, Bognanni A, Jemioło P, Vieira RJ, Nguyen TH, Munn Z, Barker TH, Bulto LN, di Bona D, Bousquet J, Dinis-Ribeiro M, Fonseca JA, Awad M, Marques-Cruz M, Schünemann HJ.   +14 more
europepmc   +2 more sources

Assessment of the efficacy of olopatadine 0.1% in the treatment of vernal keratoconjunctivitis in terms of clinical improvement based on total ocular symptom score and ocular surface disease index

Indian Journal of Ophthalmology, 2023
Purpose: The main objective of this study is to explore the efficacy of olopatadine 0.1% treatment in the resolution of symptoms of vernal keratoconjunctivitis (VKC) among the Indian population.
S Mohan, Santosh Kumar, G Pawan Kumar, Anjali Maheswari, Agrima Bhatia, Anand Sagar   +5 more
doaj   +1 more source

PHARMACOKINETIC STUDY OF OLOPATADINE 10 MG EXTENDED RELEASE TABLET IN COMPARISON WITH OLOPATADINE 5 MG IMMEDIATE RELEASE TABLET IN INDIAN POPULATION [PDF]

, 2021
Objective: This study was designed to assess the pharmacokinetics of single dose of olopatadine hydrochloride 10 mg extended release (ER) tablet of Ranbaxy laboratories limited (two test formulations) with two doses of Allelock® 5 mg immediate release ...
MARWAH, AMIT, HUSAIN, SAIYED ZEYAUL ABRAR, KHUROO, ARSHAD, VOHORA, DIVYA   +3 more
core   +1 more source

A comparative study of efficacy and safety of alcaftadine 0.25% versus olopatadine hydrochloride 0.2% in allergic conjunctivitis at a tertiary care hospital

Kerala Journal of Ophthalmology, 2022
Background: Ocular itching is the hallmark symptom of allergic conjunctivitis, accompanied by tearing, conjunctival redness, eyelid swelling, and chemosis.
Akila Krishnan, C R Jayanthi, Sriya Sridhar   +2 more
doaj   +1 more source

Combine therapy as a modern approach to treatment of allergic rhinitis

Терапевтический архив, 2021
Allergic rhinitis (AR) is one the most common allergic diseases affecting from 10 to 40% of the population in different countries, including Russia. AR is a risk factor of bronchial asthma, other upper airway disease and may decrease patient quality of ...
Alexander V. Emelyanov
doaj   +1 more source

Possibilities of combined nasal drugs in symptomatic therapy of allergic rhinitis in adolescent children

Медицинский совет, 2021
This article provides an overview of current views on the problem of allergic rhinitis (AR) in children. Modern data on the epidemiology of AR and the main comorbid conditions are highlighted.
E. P. Karpova, D. A. Tulupov
doaj   +1 more source

Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride (olopatadine), an antiallergic drug.

Folia Pharmacologica Japonica, 2001
Olopatadine is a selective histamine H1-receptor antagonist possessing inhibitory effects on the release of inflammatory lipid mediators such as leukotriene and thromboxane from human polymorphonuclear leukocytes and eosinophils. Olopatadine also inhibited the tachykininergic contraction in the guinea pig bronchi by prejunctional inhibition of ...
OHMORI, Kenji, IKEMURA, Toshihide, KOBAYASHI, Hiroyuki, MUKOUYAMA, Akimichi   +3 more
openaire   +3 more sources